User:Johnsy/Lipoprotein Modelling/References: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
Line 8: Line 8:
#Endo-1992 pmid=1464741  
#Endo-1992 pmid=1464741  
#Hussain-2000 pmid=10580165
#Hussain-2000 pmid=10580165
#Istan-2000 pmid=10698924
#Lodish-2004 isbn=071673706X
#Lodish-2004 isbn=071673706X
#Shorten-2005 pmid=16137923  
#Shorten-2005 pmid=16137923  

Revision as of 14:24, 31 October 2007

Books & Papers

  1. August E, Parker KH, and Barahona M. A dynamical model of lipoprotein metabolism. Bull Math Biol. 2007 May;69(4):1233-54. DOI:10.1007/s11538-006-9132-6 | PubMed ID:17334872 | HubMed [August-2007]
  2. Barrett PH and Watts GF. Kinetic studies of lipoprotein metabolism in the metabolic syndrome including effects of nutritional interventions. Curr Opin Lipidol. 2003 Feb;14(1):61-8. DOI:10.1097/00041433-200302000-00011 | PubMed ID:12544663 | HubMed [Barrett-2003]
  3. Brown MS and Goldstein JL. Receptor-mediated endocytosis: insights from the lipoprotein receptor system. Proc Natl Acad Sci U S A. 1979 Jul;76(7):3330-7. DOI:10.1073/pnas.76.7.3330 | PubMed ID:226968 | HubMed [Brown-1979]
  4. Brown MS and Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science. 1986 Apr 4;232(4746):34-47. DOI:10.1126/science.3513311 | PubMed ID:3513311 | HubMed [Brown-1986]
  5. Endo A. The discovery and development of HMG-CoA reductase inhibitors. J Lipid Res. 1992 Nov;33(11):1569-82. PubMed ID:1464741 | HubMed [Endo-1992]
  6. Hussain MM. A proposed model for the assembly of chylomicrons. Atherosclerosis. 2000 Jan;148(1):1-15. DOI:10.1016/s0021-9150(99)00397-4 | PubMed ID:10580165 | HubMed [Hussain-2000]
  7. Istvan ES, Palnitkar M, Buchanan SK, and Deisenhofer J. Crystal structure of the catalytic portion of human HMG-CoA reductase: insights into regulation of activity and catalysis. EMBO J. 2000 Mar 1;19(5):819-30. DOI:10.1093/emboj/19.5.819 | PubMed ID:10698924 | HubMed [Istan-2000]
  8. ISBN:071673706X [Lodish-2004]
  9. Shorten PR and Upreti GC. A mathematical model of fatty acid metabolism and VLDL assembly in human liver. Biochim Biophys Acta. 2005 Sep 15;1736(2):94-108. DOI:10.1016/j.bbalip.2005.07.007 | PubMed ID:16137923 | HubMed [Shorten-2005]
  10. ISBN:047119350X [Voet-2004]
  11. Willnow TE, Nykjaer A, and Herz J. Lipoprotein receptors: new roles for ancient proteins. Nat Cell Biol. 1999 Oct;1(6):E157-62. DOI:10.1038/14109 | PubMed ID:10559979 | HubMed [Willnow-1999]

All Medline abstracts: PubMed | HubMed

Other Books and Sources

  1. Brown M & Goldstein J, Receptor-mediated endocytosis: Insights from the lipoprotein receptor system, Proc. Nat. Acad. Sci., 76, 3330-3337 (1979)
  2. Brown M & Goldstein J, A Receptor Mediated Pathway for Cholesterol Homeostasis, Nobel Prize Lecture, 9 December 1985
  3. Feher, M. 1997, Lipids and Lipid Disorders, 2nd edn, Mosby-Wolfe, London.
  4. Panovska J, et al. 2006. Mathematical Models of Hepatic Lipoprotein Metabolism. 5th Mathematics in Medicine Study Group, Oxford University
  5. Ratushny A, et al. Mathematical Model of Cholesterol Biosynthesis Regulation in the Cell. Institute of Cytology and Genetics SB RAS, Russia

Wikitext Markup References

  1. Wikipedia Help: Displaying a formula